Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials.
In recent years it has been recognized that bacteriophages have several potential applications in the modern biotechnology industry: they have been proposed as delivery vehicles for protein and DNA vaccines; as gene therapy delivery vehicles; as alternatives to antibiotics; for the detection of pathogenic bacteria; and as tools for screening libraries of proteins, peptides or antibodies. This diversity, and the ease of their manipulation and production, means that they have potential uses in research, therapeutics and manufacturing in both the biotechnology and medical fields. It is hoped that the wide range of scientists, clinicians and biotechnologists currently researching or putting phages to practical use are able to pool their knowledge and expertise and thereby accelerate progress towards further development in this exciting field of biotechnology.
Clark
Jason R
JR
Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik, Midlothian, EH26 0PZ, UK. Jason.Clark@moredun.ac.uk
March
John B
JB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000235:genetics* / Q000517:prevention & control*; D001435:Bacteriophages / Q000235:genetics*; D001709:Biotechnology / Q000639:trends; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D014611:Vaccination / Q000639:trends*; D014765:Viral Vaccines
D000900:Anti-Bacterial Agents; D014765:Viral Vaccines